Director Paul J. Fribourg Increases Stake in IFF
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2026
0mins
Should l Buy IFF?
Source: NASDAQ.COM
International Flavors & Fragrances Inc's stock fell 4.01% and hit a 20-day low amid broader market declines, with the Nasdaq-100 down 1.16% and the S&P 500 down 1.21%.
Despite the stock's decline, director Paul J. Fribourg purchased 156,459 shares at $70.12 each, totaling $10.97 million, indicating strong confidence in the company's future prospects. This investment reflects Fribourg's ongoing interest, as he had previously acquired shares worth $1.00 million at $64.80 each over the past year. The market's reaction to this purchase may help bolster investor confidence in IFF.
Fribourg's significant investment could signal potential recovery for IFF, especially as it contrasts with the current market conditions. Investors may view this as a positive sign, potentially leading to a rebound in stock performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IFF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IFF
Wall Street analysts forecast IFF stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 75.880
Low
68.00
Averages
80.66
High
89.00
Current: 75.880
Low
68.00
Averages
80.66
High
89.00
About IFF
International Flavors & Fragrances Inc. is a creator and manufacturer of products for application in food, beverage, health and biosciences, scent and complementary adjacent products. Its segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IFF to Release Q1 2026 Earnings Results on May 5
- Earnings Release Schedule: IFF has announced that it will release its Q1 2026 earnings results after market close on May 5, 2026, which is expected to provide key financial data and future outlook to help investors assess the company's performance.
- Management Webcast: The management team will host a live webcast on May 6, 2026, at 9:00 a.m. ET to discuss the earnings results and future strategies, enhancing interaction and transparency with investors.
- Investor Access Channels: Investors can access the live webcast and accompanying slides on IFF's website, ensuring broad dissemination of information, while a recorded version will be available for those unable to attend the live session.
- Company Vision and Innovation: IFF emphasizes its position as a global leader in taste, scent, and food ingredients, committed to driving sustainable solutions through science and creativity, thereby enhancing consumer experience and health outcomes.
See More
UBS Lowers Target Price for International Flavors & Fragrances Inc. to $75 from $85
- Price Adjustment: International Flavors & Fragrances has reduced its target price from $85 to $75.
- Market Impact: This price cut may reflect changes in market conditions or company performance expectations.
See More
IFF Launches PureStrong™, Probiotic Specifically Designed for Dogs
- Significant Market Potential: The U.S. pet supplement market is valued at $3.2 billion, with nearly half of pet owners having purchased or considering probiotics for their dogs, positioning PureStrong™ to meet this rapidly growing demand and solidify IFF's leadership in pet health.
- Science-Driven Innovation: PureStrong™ utilizes a single strain of Limosilactobacillus reuteri sourced directly from the microbiome of healthy canines, specifically designed for canine biology, ensuring its survival and attachment in dogs' guts, thus providing targeted digestive health support and enhancing market competitiveness.
- Improved Digestive Health: In a controlled study of healthy dogs undergoing abrupt dietary changes, those receiving PureStrong™ showed improved digestive health and hydration markers, resulting in firmer stools, helping pet owners better manage their dogs' daily digestive challenges.
- Brand Differentiation Advantage: The launch of PureStrong™ not only provides a clear differentiation point for pet supplement brands but also drives a shift from trend-driven formulations to precision wellness, enhancing IFF's influence in the pet health market through scientific backing and clinical evaluation.
See More
Sensient Technologies Set for Growth as Shift to Natural Dyes Accelerates
- Market Transformation Opportunity: According to UBS, U.S. food producers and grocers are transitioning from synthetic dyes to natural colorants, which is expected to create significant growth opportunities for Sensient Technologies, with analyst Joshua Spector noting this shift will act as a positive catalyst for the company's stock.
- Price Target Increase: UBS initiated coverage with a buy rating on Sensient, setting a price target of $115, implying a 33% upside from Tuesday's close, reflecting confidence in the company's future growth potential.
- Sales Growth Expectations: By 2030, Sensient's color group sales are projected to increase by over 200% due to the growing adoption of natural food colorings, significantly enhancing the company's market share and profitability, particularly in North America.
- Analyst Consensus: Among the three analysts covering Sensient, two have assigned strong buy or buy ratings, indicating a general optimism about the company's future performance, despite its shares having fallen nearly 3% year-to-date.
See More
Australia and New Zealand Approve Heart Health Claim for Soy Protein
- Heart Health Claim Approval: IFF announced that the Food Standards Australia New Zealand has accepted the heart health claim for isolated soy protein, enabling food and beverage manufacturers to link soy protein consumption with healthy blood cholesterol levels, which is expected to drive market demand for related products.
- Scientific Research Support: This claim is backed by years of cross-continental research involving IFF, the Soy Nutrition Institute Global, and the U.S. Soybean Export Council, demonstrating a causal relationship between isolated soy protein consumption and improved blood lipids, thereby enhancing consumer confidence in the product.
- Expanded Market Opportunities: Under the new approval, foods containing 20-25 grams of isolated soy protein can carry the heart health claim, providing manufacturers with opportunities to develop new products that meet consumer demands for both health and taste, particularly in the plant-based food sector.
- Significant Industry Impact: This approval positions Australia and New Zealand among 13 countries recognizing the link between soy protein and heart health, with IFF leveraging its SOLAE® SUPRO® soy protein portfolio to assist clients in developing next-generation nutritional products, thereby driving growth in the plant-based nutrition market.
See More
Analysis of International Flavors & Fragrances Stock Performance
- Stock Performance: International Flavors & Fragrances (IFF) has shown a year-to-date stock price increase of 2.8%, indicating cautious optimism in the market regarding its future growth potential despite overall market volatility.
- Analyst Opinions: The ranking is derived from averaging analyst opinions for each component, suggesting a relatively stable market perception of IFF, which may help attract more investor attention.
- Market Impact: While IFF's stock price has risen, the overall market environment remains complex, prompting investors to monitor upcoming financial reports and market dynamics to assess the feasibility of continued growth.
- Investor Confidence: The analysts' opinions reflect confidence in IFF, which could influence investor decisions, particularly against the backdrop of increasing economic uncertainty.
See More
IFF to Release Q1 2026 Earnings Results on May 5
- Earnings Release Schedule: IFF has announced that it will release its Q1 2026 earnings results after market close on May 5, 2026, which is expected to provide key financial data and future outlook to help investors assess the company's performance.
- Management Webcast: The management team will host a live webcast on May 6, 2026, at 9:00 a.m. ET to discuss the earnings results and future strategies, enhancing interaction and transparency with investors.
- Investor Access Channels: Investors can access the live webcast and accompanying slides on IFF's website, ensuring broad dissemination of information, while a recorded version will be available for those unable to attend the live session.
- Company Vision and Innovation: IFF emphasizes its position as a global leader in taste, scent, and food ingredients, committed to driving sustainable solutions through science and creativity, thereby enhancing consumer experience and health outcomes.
See More
UBS Lowers Target Price for International Flavors & Fragrances Inc. to $75 from $85
- Price Adjustment: International Flavors & Fragrances has reduced its target price from $85 to $75.
- Market Impact: This price cut may reflect changes in market conditions or company performance expectations.
See More
IFF Launches PureStrong™, Probiotic Specifically Designed for Dogs
- Significant Market Potential: The U.S. pet supplement market is valued at $3.2 billion, with nearly half of pet owners having purchased or considering probiotics for their dogs, positioning PureStrong™ to meet this rapidly growing demand and solidify IFF's leadership in pet health.
- Science-Driven Innovation: PureStrong™ utilizes a single strain of Limosilactobacillus reuteri sourced directly from the microbiome of healthy canines, specifically designed for canine biology, ensuring its survival and attachment in dogs' guts, thus providing targeted digestive health support and enhancing market competitiveness.
- Improved Digestive Health: In a controlled study of healthy dogs undergoing abrupt dietary changes, those receiving PureStrong™ showed improved digestive health and hydration markers, resulting in firmer stools, helping pet owners better manage their dogs' daily digestive challenges.
- Brand Differentiation Advantage: The launch of PureStrong™ not only provides a clear differentiation point for pet supplement brands but also drives a shift from trend-driven formulations to precision wellness, enhancing IFF's influence in the pet health market through scientific backing and clinical evaluation.
See More
Sensient Technologies Set for Growth as Shift to Natural Dyes Accelerates
- Market Transformation Opportunity: According to UBS, U.S. food producers and grocers are transitioning from synthetic dyes to natural colorants, which is expected to create significant growth opportunities for Sensient Technologies, with analyst Joshua Spector noting this shift will act as a positive catalyst for the company's stock.
- Price Target Increase: UBS initiated coverage with a buy rating on Sensient, setting a price target of $115, implying a 33% upside from Tuesday's close, reflecting confidence in the company's future growth potential.
- Sales Growth Expectations: By 2030, Sensient's color group sales are projected to increase by over 200% due to the growing adoption of natural food colorings, significantly enhancing the company's market share and profitability, particularly in North America.
- Analyst Consensus: Among the three analysts covering Sensient, two have assigned strong buy or buy ratings, indicating a general optimism about the company's future performance, despite its shares having fallen nearly 3% year-to-date.
See More
Australia and New Zealand Approve Heart Health Claim for Soy Protein
- Heart Health Claim Approval: IFF announced that the Food Standards Australia New Zealand has accepted the heart health claim for isolated soy protein, enabling food and beverage manufacturers to link soy protein consumption with healthy blood cholesterol levels, which is expected to drive market demand for related products.
- Scientific Research Support: This claim is backed by years of cross-continental research involving IFF, the Soy Nutrition Institute Global, and the U.S. Soybean Export Council, demonstrating a causal relationship between isolated soy protein consumption and improved blood lipids, thereby enhancing consumer confidence in the product.
- Expanded Market Opportunities: Under the new approval, foods containing 20-25 grams of isolated soy protein can carry the heart health claim, providing manufacturers with opportunities to develop new products that meet consumer demands for both health and taste, particularly in the plant-based food sector.
- Significant Industry Impact: This approval positions Australia and New Zealand among 13 countries recognizing the link between soy protein and heart health, with IFF leveraging its SOLAE® SUPRO® soy protein portfolio to assist clients in developing next-generation nutritional products, thereby driving growth in the plant-based nutrition market.
See More
Analysis of International Flavors & Fragrances Stock Performance
- Stock Performance: International Flavors & Fragrances (IFF) has shown a year-to-date stock price increase of 2.8%, indicating cautious optimism in the market regarding its future growth potential despite overall market volatility.
- Analyst Opinions: The ranking is derived from averaging analyst opinions for each component, suggesting a relatively stable market perception of IFF, which may help attract more investor attention.
- Market Impact: While IFF's stock price has risen, the overall market environment remains complex, prompting investors to monitor upcoming financial reports and market dynamics to assess the feasibility of continued growth.
- Investor Confidence: The analysts' opinions reflect confidence in IFF, which could influence investor decisions, particularly against the backdrop of increasing economic uncertainty.
See More
